Oncology

Inhibiting TGF-beta Receptor Type 1 may have a negative impact on breast cancer therapy.

Improved response rates and extended periods of disease remission found with precision medicine.

Nivolumab blocks the activation of the protein PD-1 to prompt an attack by the immune system.

Rovalpituzumab tesirine (Rova-T) is an antibody-drug conjugate that binds to a protein highly expressed in about two-thirds of SCLC tumors.

Providers need to better inform patients about the risks of heart disease compared with breast cancer.

Rovalpituzumab tesirine is an antibody-drug conjugate that binds to a protein highly expressed in about two-thirds of SCLC tumors.

Patients who underwent surgery and then standard treatment lived 9 months longer than patients who just had the standard treatment.

The compound 2-bromo-palmitate has the ability to inhibit EGFR.

Pembrolizumab found to prevent disease progression in 54.5% of patients with advanced thyroid cancer.

Recent advances and updates in oncology and cancer drug development.

Gel nano-capsules with 2 shells keep drug molecules safe in transit.

Currently, no consensus exists about whether chemotherapy or radiation should be used to treat early stage 2 testicular cancer.

Unbalance chloride levels be restored to stop cancer-related neuropathic pain.

Top articles of the day from across the health care landscape.

Pembrolizumab found to prevent disease progression in 54.5% of patients with advanced thyroid cancer.

Elderly African American multiple myeloma patients had lower rates of access to autologous stem cell transplant.

Increased fat deposits consistent with obesity experienced disease relapse.

Patients who underwent surgery and then standard treatment lived 9 months longer than patients who just had the standard treatment.

Providers need to better inform patients about the risks of obesity and heart disease compared with breast cancer.

Approximately half of all cancer deaths may be preventable by behavior modifications.

APR-246 was seen to successfully target mutated p53 genes in patients with cancer.

Breast cancer treatments that are similar in effectiveness are priced very differently, researchers discovered.

Radon already associated with lung cancer development.

Treatment with avasimibe causes pancreatic cancer cells to become more sensitive to ACAT-1 inhibition.

Combination imaging found to reduce recall rate in patients with breast cancer.

Granix is a human granulocyte factor produced in a bioreactor using recombinant DNA technology.

Informed choices of therapy regimens could save up to $1 billion annually in cancer drug spending.

Top news of the day from across the health care landscape.